Ocular Health Market Growth Strategy
Committed to delivering significant margin expansion
Core operating margin 1,2
(% of sales)
Mid-to-high
teens %
2018
Alcon
Drivers of margin improvement
Sales acceleration on the back
of near term growth drivers
and new innovation
Low-to-mid
20%
+
Favorable product mix
Gross Margin
improvement
Operational efficieny
and P&L leverage
2023E
2.5 year outlook for our core operating margin expansion is subject to various risks and uncertainties. See "Legal Disclaimers" on slide 2
1. Core operating margin is a non-IFRS measure
+
Manufacturing efficiencies from
new lower cost contact lens
platforms
SG&A improvement as we
leverage existing infrastructure
(built up during turnaround
phase)
Process & cost efficiencies
from global business services
and reaping benefits of SAP
implementation
23
23View entire presentation